SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Polly J. Ferguson, Ronald M. Laxer, Textbook of Pediatric Rheumatology, 2016,

    CrossRef

  2. 2
    Karyl S. Barron, Daniel L. Kastner, Textbook of Pediatric Rheumatology, 2016,

    CrossRef

  3. 3
    Ezgi Ulusoy, Neslihan Edeer Karaca, Hatem El-Shanti, Erhan Kilicoglu, Guzide Aksu, Necil Kutukculer, Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report, Journal of Medical Case Reports, 2015, 9, 1

    CrossRef

  4. 4
    Piero Ruscitti, Paola Cipriani, Francesco Carubbi, Vasiliki Liakouli, Francesca Zazzeroni, Paola Di Benedetto, Onorina Berardicurti, Edoardo Alesse, Roberto Giacomelli, The Role of IL-1βin the Bone Loss during Rheumatic Diseases, Mediators of Inflammation, 2015, 2015, 1

    CrossRef

  5. 5
    Claudia J. Posso-De Los Rios, Elena Pope, New insights into pustular dermatoses in pediatric patients, Journal of the American Academy of Dermatology, 2014, 70, 4, 767

    CrossRef

  6. 6
    Polly J. Ferguson, Raphaela Goldbach-Mansky, Stiehm's Immune Deficiencies, 2014,

    CrossRef

  7. 7
    Sara M. Stern, Polly J. Ferguson, Autoinflammatory Bone Diseases, Rheumatic Disease Clinics of North America, 2013, 39, 4, 735

    CrossRef

  8. 8
    Manisha Sharma, Polly J. Ferguson, Autoinflammatory bone disorders, Current Opinion in Rheumatology, 2013, 25, 5, 658

    CrossRef

  9. 9
    Henner Morbach, Christian M. Hedrich, Meinrad Beer, Hermann J. Girschick, Autoinflammatory bone disorders, Clinical Immunology, 2013, 147, 3, 185

    CrossRef

  10. 10
    Haley B. Naik, Edward W. Cowen, Autoinflammatory Pustular Neutrophilic Diseases, Dermatologic Clinics, 2013, 31, 3, 405

    CrossRef

  11. 11
    Antonio Vitale, Donato Rigante, Orso Maria Lucherini, Francesco Caso, Isabella Muscari, Flora Magnotti, Maria Giuseppina Brizi, Susanna Guerrini, Maria Patti, Leonardo Punzi, Mauro Galeazzi, Luca Cantarini, Biological Treatments: New Weapons in the Management of Monogenic Autoinflammatory Disorders, Mediators of Inflammation, 2013, 2013, 1

    CrossRef

  12. 12
    Waheeb Sakran, Stavit A Shalev, Waheeb Sakran, Stavit A Shalev, Hatem El-Shanti, Yosef Uziel, Yosef Uziel, Chronic Recurrent Multifocal Osteomyelitis and Deficiency of Interleukin-1–receptor Antagonist, The Pediatric Infectious Disease Journal, 2013, 32, 1, 94

    CrossRef

  13. 13
    Monika Moll, Jasmin B. Kuemmerle-Deschner, Inflammasome and cytokine blocking strategies in autoinflammatory disorders, Clinical Immunology, 2013, 147, 3, 242

    CrossRef

  14. 14
    Adriana Almeida de Jesus, Raphaela Goldbach-Mansky, Monogenic autoinflammatory diseases: Concept and clinical manifestations, Clinical Immunology, 2013, 147, 3, 155

    CrossRef

  15. 15
    Francesco Caso, Donato Rigante, Antonio Vitale, Orso Maria Lucherini, Luisa Costa, Mariangela Atteno, Adele Compagnone, Paolo Caso, Bruno Frediani, Mauro Galeazzi, Leonardo Punzi, Luca Cantarini, Monogenic Autoinflammatory Syndromes: State of the Art on Genetic, Clinical, and Therapeutic Issues, International Journal of Rheumatology, 2013, 2013, 1

    CrossRef

  16. 16
    Ender Altiok, Figen Aksoy, Yıldız Perk, Fulya Taylan, Peter W. Kim, Barbaros Ilıkkan, Gülten Turkkani Asal, Raphaela Goldbach-Mansky, Ozden Sanal, A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset, Clinical Immunology, 2012, 145, 1, 77

    CrossRef

  17. 17
    Roberta Caorsi, Silvia Federici, Marco Gattorno, Biologic drugs in autoinflammatory syndromes, Autoimmunity Reviews, 2012, 12, 1, 81

    CrossRef

  18. 18
    Polly J. Ferguson, Monica Sandu, Current Understanding of the Pathogenesis and Management of Chronic Recurrent Multifocal Osteomyelitis, Current Rheumatology Reports, 2012, 14, 2, 130

    CrossRef

  19. 19
    F. L. van de Veerdonk, A. K. Stoeckman, G. Wu, A. N. Boeckermann, T. Azam, M. G. Netea, L. A. B. Joosten, J. W. M. van der Meer, R. Hao, V. Kalabokis, C. A. Dinarello, IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist, Proceedings of the National Academy of Sciences, 2012, 109, 8, 3001

    CrossRef

  20. You have free access to this content20
    R. Goldbach-Mansky, Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1, Clinical & Experimental Immunology, 2012, 167, 3